Works matching DE "RAF genes"
Results: 88
Raf kinases in signal transduction and interaction with translation machinery.
- Published in:
- Biomolecular Concepts, 2013, v. 4, n. 4, p. 391, doi. 10.1515/bmc-2013-0003
- By:
- Publication type:
- Article
A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0467-z
- By:
- Publication type:
- Article
αC IN, αC OUT-that's what it's all about.
- Published in:
- Pigment Cell & Melanoma Research, 2017, v. 30, n. 2, p. 177, doi. 10.1111/pcmr.12549
- By:
- Publication type:
- Article
Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2017, v. 30, n. 2, p. 233, doi. 10.1111/pcmr.12569
- By:
- Publication type:
- Article
<sup>G12D</sup> NRAS and kinase-dead BRAF cooperate to drive naevogenesis and melanomagenesis.
- Published in:
- Pigment Cell & Melanoma Research, 2014, v. 27, n. 6, p. 1162, doi. 10.1111/pcmr.12293
- By:
- Publication type:
- Article
Resistance to vemurafenib resulting from a novel mutation in the BRAFV600 E kinase domain.
- Published in:
- Pigment Cell & Melanoma Research, 2014, v. 27, n. 1, p. 124, doi. 10.1111/pcmr.12171
- By:
- Publication type:
- Article
Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 4, p. 509, doi. 10.1111/pcmr.12092
- By:
- Publication type:
- Article
Active surrender.
- Published in:
- Pigment Cell & Melanoma Research, 2012, v. 25, n. 3, p. 292, doi. 10.1111/j.1755-148X.2012.00991.x
- By:
- Publication type:
- Article
Senescence-escape in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2012, v. 25, n. 4, p. 408, doi. 10.1111/j.1755-148X.2012.01021.x
- By:
- Publication type:
- Article
CD45RAFoxp3 regulatory T cells have a negative impact on the clinical outcome of head and neck squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1275, doi. 10.1007/s00262-017-2021-z
- By:
- Publication type:
- Article
Pentoxifylline inhibits hepatic stellate cells proliferation via the Raf/ ERK pathway.
- Published in:
- APMIS, 2012, v. 120, n. 7, p. 572, doi. 10.1111/j.1600-0463.2011.02868.x
- By:
- Publication type:
- Article
T cell leukemia control via Ras-Raf pathway inhibition with peptides.
- Published in:
- Journal of Medicine & Life, 2017, v. 10, n. 3, p. 172
- By:
- Publication type:
- Article
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 10, p. 2088, doi. 10.1038/bjc.2013.197
- By:
- Publication type:
- Article
Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 10, p. 2164, doi. 10.1038/bjc.2013.143
- By:
- Publication type:
- Article
The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 10, p. 2153, doi. 10.1038/bjc.2013.212
- By:
- Publication type:
- Article
In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 6, p. 1298, doi. 10.1038/bjc.2013.64
- By:
- Publication type:
- Article
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state.
- Published in:
- Molecular Systems Biology, 2017, v. 13, n. 1, p. n/a, doi. 10.15252/msb.20166796
- By:
- Publication type:
- Article
An amino-terminal BRAF deletion accounting for acquired resistance to RAF/EGFR inhibition in colorectal cancer.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2020, v. 6, n. 4, p. 1, doi. 10.1101/mcs.a005140
- By:
- Publication type:
- Article
Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.
- Published in:
- Journal of Physiology, 2017, v. 595, n. 12, p. 4073, doi. 10.1113/JP274064
- By:
- Publication type:
- Article
BRAF V600E-Negative Hairy Cell Leukaemia.
- Published in:
- Case Reports in Hematology, 2013, p. 1, doi. 10.1155/2013/513049
- By:
- Publication type:
- Article
Stimulation of β-adrenergic receptors plays a protective role via increased expression of RAF-1 and PDX-1 in hyperglycemic rat pancreatic islet (RIN-m5F) cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anti-inflammatory effects of dabrafenib in vitro and in vivo.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2017, v. 95, n. 6, p. 697, doi. 10.1139/cjpp-2016-0519
- By:
- Publication type:
- Article
An association between the reduced levels of SLC1A2 and GAD1 in the dorsolateral prefrontal cortex in major depressive disorder: possible involvement of an attenuated RAF/MEK/ERK signaling pathway.
- Published in:
- Journal of Neural Transmission, 2014, v. 121, n. 7, p. 783, doi. 10.1007/s00702-014-1189-z
- By:
- Publication type:
- Article
RKIP and 14-3-3ε Exert an Opposite Effect on Human Gastric Cancer Cells SGC7901 by Regulating the ERK/MAPK Pathway Differently.
- Published in:
- Digestive Diseases & Sciences, 2013, v. 58, n. 2, p. 389, doi. 10.1007/s10620-012-2341-y
- By:
- Publication type:
- Article
The Ras/ MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.
- Published in:
- European Journal of Clinical Investigation, 2015, v. 45, n. 6, p. 609, doi. 10.1111/eci.12441
- By:
- Publication type:
- Article
Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-12
- By:
- Publication type:
- Article
Follicular variant of papillary thyroid carcinoma with B-type Raf<sup>V600E</sup> showing higher frequency of suspicious sonographic features and multifocality.
- Published in:
- Head & Neck, 2015, v. 37, n. 11, p. 1590, doi. 10.1002/hed.23793
- By:
- Publication type:
- Article
B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy.
- Published in:
- Cardiovascular Research, 2014, v. 102, n. 1, p. 88, doi. 10.1093/cvr/cvu024
- By:
- Publication type:
- Article
Identification of a novel MTAP-RAF1 fusion in a soft tissue sarcoma.
- Published in:
- Diagnostic Pathology, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13000-018-0759-z
- By:
- Publication type:
- Article
The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
- Published in:
- Biology of the Cell (Wiley-Blackwell), 2013, v. 105, n. 2, p. 91, doi. 10.1111/boc.201200030
- By:
- Publication type:
- Article
Tumor adaptation and resistance to RAF inhibitors.
- Published in:
- Nature Medicine, 2013, v. 19, n. 11, p. 1401, doi. 10.1038/nm.3392
- By:
- Publication type:
- Article
Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells.
- Published in:
- Lipids in Health & Disease, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-511X-12-101
- By:
- Publication type:
- Article
The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib.
- Published in:
- Acta Pharmacologica Sinica, 2012, v. 33, n. 10, p. 1311, doi. 10.1038/aps.2012.76
- By:
- Publication type:
- Article
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185862
- By:
- Publication type:
- Article
Molecular mechanisms of asymmetric RAF dimer activation.
- Published in:
- Biochemical Society Transactions, 2014, v. 42, n. 4, p. 784, doi. 10.1042/BST20140025
- By:
- Publication type:
- Article
C- Raf deficiency leads to hearing loss and increased noise susceptibility.
- Published in:
- Cellular & Molecular Life Sciences, 2015, v. 72, n. 20, p. 3983, doi. 10.1007/s00018-015-1919-x
- By:
- Publication type:
- Article
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
- Published in:
- Nature Genetics, 2015, v. 47, n. 3, p. 250, doi. 10.1038/ng.3218
- By:
- Publication type:
- Article
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 5, p. 2155, doi. 10.1172/JCI65780
- By:
- Publication type:
- Article
Hepatitis B virus regulation of Raf1 promoter activity through activation of transcription factor AP-2α.
- Published in:
- 2013
- By:
- Publication type:
- Report
Targeted therapy for melanoma: rational combinatorial approaches.
- Published in:
- Oncogene, 2014, v. 33, n. 1, p. 1, doi. 10.1038/onc.2013.34
- By:
- Publication type:
- Article
Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis.
- Published in:
- Oncogene, 2013, v. 32, n. 19, p. 2483, doi. 10.1038/onc.2012.254
- By:
- Publication type:
- Article
Mechanisms of acquired resistance to ERK1/2 pathway inhibitors.
- Published in:
- Oncogene, 2013, v. 32, n. 10, p. 1207, doi. 10.1038/onc.2012.160
- By:
- Publication type:
- Article
Phosphorylation of Mps1 by BRAF<sup>V600E</sup> prevents Mps1 degradation and contributes to chromosome instability in melanoma.
- Published in:
- Oncogene, 2013, v. 32, n. 6, p. 713, doi. 10.1038/onc.2012.94
- By:
- Publication type:
- Article
Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane.
- Published in:
- Oncogene, 2013, v. 32, n. 6, p. 777, doi. 10.1038/onc.2012.86
- By:
- Publication type:
- Article
Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
- Published in:
- Oncogene, 2012, v. 31, n. 46, p. 4848, doi. 10.1038/onc.2011.644
- By:
- Publication type:
- Article
A novel Noonan syndrome RAF1 mutation: lethal course in a preterm infant.
- Published in:
- Pediatric Reports, 2015, v. 7, n. 2, p. 35, doi. 10.4081/pr.2015.5955
- By:
- Publication type:
- Article
The importance of Raf dimerization in cell signaling.
- Published in:
- Small GTPases, 2013, v. 4, n. 3, p. 180, doi. 10.4161/sgtp.26117
- By:
- Publication type:
- Article
Correction.
- Published in:
- 2012
- Publication type:
- Correction Notice
A-Raf: A new star of the family of raf kinases.
- Published in:
- Critical Reviews in Biochemistry & Molecular Biology, 2015, v. 50, n. 6, p. 520, doi. 10.3109/10409238.2015.1102858
- By:
- Publication type:
- Article
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.
- Published in:
- Immunogenetics, 2013, v. 65, n. 10, p. 703, doi. 10.1007/s00251-013-0717-6
- By:
- Publication type:
- Article